These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8332961)

  • 1. Effect of molsidomine and free radical scavengers on the pulmonary thromboembolism in mice.
    Dikshit M; Seth P; Srimal RC
    Thromb Res; 1993 May; 70(4):317-27. PubMed ID: 8332961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats.
    Elmedal B; de Dam MY; Mulvany MJ; Simonsen U
    Br J Pharmacol; 2004 Jan; 141(1):105-13. PubMed ID: 14656807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of platelet functions by molsidomine in animals].
    Just M; Martorana PA; Nitz RE
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):226-8. PubMed ID: 3550643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombotic effects of molsidomine alone and in combination with other antithrombotic agents in a thrombosis model of the microcirculation of the rat].
    Giedrojc J; Weichert W; Breddin HK
    Z Kardiol; 1991; 80 Suppl 5():35-9. PubMed ID: 1663678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of coronary artery thrombosis by SIN-1, a donor of nitric oxide.
    Ovize M; de Lorgeril M; Cathignol D; Delaye J; Renaud S
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):641-5. PubMed ID: 1706807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of molsidomine on ex vivo platelet aggregation and plasma guanosine 3':5'-cyclic monophosphate levels in healthy volunteers.
    Karrenbrock B; Heim JM; Gerzer R
    Klin Wochenschr; 1990 Feb; 68(4):213-7. PubMed ID: 2156106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
    Bult H; Fret HR; Herman AG
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S120-3. PubMed ID: 2484689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.
    Sinzinger H; Rauscha F; O'Grady J; Fitscha P
    Br J Clin Pharmacol; 1992 Mar; 33(3):289-92. PubMed ID: 1576049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of occlusive coronary artery thrombosis and myocardial ischemia by molsidomine in anesthetized dogs.
    Fiedler VB
    Can J Physiol Pharmacol; 1982 Aug; 60(8):1104-11. PubMed ID: 6897011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
    Gerzer R; Drummer C; Karrenbrock B; Heim JM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against concanavalin A-induced hepatocyte apoptosis by molsidomine is time-dependent.
    Ding JW; Wang K; Brems JJ; Gamelli RL
    J Am Coll Surg; 2004 Jan; 198(1):67-77. PubMed ID: 14698313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
    Lorenc-Koci E; Czarnecka A; Lenda T; Kamińska K; Konieczny J
    Neurochem Int; 2013 Dec; 63(8):790-804. PubMed ID: 24090640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocyte aggregation and fibrinolysis in healthy probands treated with molsidomine, isosorbide-5-mononitrate and placebo].
    Drummer C; Valta-Seufzer U; Spannagl M; Frey A; Lüdke S; Schramm W; Gerzer R
    Z Kardiol; 1991; 80 Suppl 5():43-6. PubMed ID: 1776334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molsidomine, a nitric oxide donor and L-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure.
    Chander V; Chopra K
    Biochim Biophys Acta; 2005 May; 1723(1-3):208-14. PubMed ID: 15777642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of molsidomine on thrombus formation in stenosed coronary arteries of dogs and pigs.
    Just M; Martorana PA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S129-36. PubMed ID: 2484691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of molsidomine on changes in oxidant/antioxidant status of rat erythrocytes].
    Maletić SD; Ognjanović BI; Stajn AS; Zikić RV; Spasić MB; Saicić ZS
    Med Pregl; 2003; 56 Suppl 1():73-7. PubMed ID: 15510918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving rats.
    Serra PA; Rocchitta G; Esposito G; Delogu MR; Migheli R; Miele E; Desole MS; Miele M
    Br J Pharmacol; 2001 Sep; 134(2):275-82. PubMed ID: 11564645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light and scanning-electron microscopic examination of coronary stents in a perfusion-model. Effects of an NO-donor/quantitative analysis.
    Franke RP; Reuter P; Mrowietz C; Bach R; Jung F
    Clin Hemorheol Microcirc; 2001; 24(2):101-9. PubMed ID: 11381185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term exposure of endothelial cells to molsidomine increases their antithrombogenicity by inducing the production of nitric oxide-related chemical substances.
    Berenger-Bahuet FP; Rolland PH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S98-105. PubMed ID: 2484710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide donor-induced hyperpermeability of cultured intestinal epithelial monolayers: role of superoxide radical, hydroxyl radical, and peroxynitrite.
    Menconi MJ; Unno N; Smith M; Aguirre DE; Fink MP
    Biochim Biophys Acta; 1998 Sep; 1425(1):189-203. PubMed ID: 9813320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.